Back to top
more

West Pharmaceutical Services (WST)

(Delayed Data from NYSE)

$314.77 USD

314.77
496,482

-1.73 (-0.55%)

Updated Nov 4, 2024 04:00 PM ET

After-Market: $315.11 +0.34 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Merit Medical's (MMSI) Q2 Earnings Top Estimates, '21 View Up

Merit Medical (MMSI), in the second quarter, benefits from revenue growth across both its segments as well as across all the product categories within its Cardiovascular unit.

Integer Holdings (ITGR) Beats on Q2 Earnings, Ups 2021 View

Integer Holdings' (ITGR) second-quarter results reflect robust segmental performances along with strength in majority of the product lines.

QIAGEN (QGEN) Q2 Earnings Top Estimates, Margins Decline

Faster-than-expected vaccination uptake leads to a reduction in demand for COVID-19 testing for QIAGEN (QGEN) in Q2.

Teleflex (TFX) Q2 Earnings Surpass Estimates, Margins Up

Teleflex (TFX) reports better-than-expected revenues with strong segmental and geographical performance driving the top line in second-quarter 2021.

Omnicell (OMCL) Q2 Earnings Top Estimates, 2021 EPS View Up

Omnicell (OMCL) reports better-than-expected revenues on strong segmental performance driving the top line in second-quarter 2021.

Bio-Rad (BIO) Q2 Earnings Top Estimates, 2021 View Raised

Strength in Life Science and Clinical Diagnostics segments during the second quarter drove Bio-Rad (BIO) revenues.

IDEXX (IDXX) Q2 Earnings Beat Estimates, 2021 Guidance Up

Strength in CAG Diagnostics and Water businesses drove IDEXX's (IDXX) second-quarter revenues.

Edwards Lifesciences (EW) Beats on Q2 Earnings, Margins Up

Strong sales growth across all four products along with steady improvement in surgical procedure volumes during the second quarter drove Edwards Lifesciences' (EW) revenues.

DexCom (DXCM) Q2 Earnings and Revenues Surpass Estimates

DexCom's (DXCM) second-quarter results benefit from domestic and international revenue growth and solid new customer additions.

NextGen Healthcare (NXGN) Q1 Earnings & Revenues Top Estimates

NextGen Healthcare's (NXGN) fiscal first-quarter earnings reflect strong segmental performance.

Cerner (CERN) Q2 Earnings and Revenues Surpass Estimates

Cerner's (CERN) second-quarter results benefit from gains across six of its business units.

LabCorp (LH) Q2 Earnings Surpass Estimates, 2021 View Raised

LabCorp (LH) Diagnostics revenues in the second quarter increase significantly on organic Base Business volume improvements despite decelerating demand for COVID-19 testing.

West Pharmaceutical (WST) Q2 Earnings & Revenues Top Estimates

West Pharmaceutical's (WST) second-quarter earnings reflect strong segmental performance.

Hologic's (HOLX) Q3 Earnings Top Estimates, Q4 View Dull

Impressive performance by the Breast Health and GYN Surgical segments drive Hologic's (HOLX) fiscal third-quarter revenues.

Align Technology (ALGN) Q2 Earnings Top Estimates, 2021 View Up

Strength in Invisalign Clear Aligners and iTero scanners sales volumes during the fiscal second quarter drove Align Technology's (ALGN) top line.

West Pharmaceutical Services (WST) Surpasses Q2 Earnings and Revenue Estimates

West Pharmaceutical (WST) delivered earnings and revenue surprises of 41.38% and 8.72%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Masimo's (MASI) Q2 Earnings Surpass Estimates, '21 View Up

Masimo's (MASI) robust product shipments, along with strong rebound in sensor sales, drive its Q2 sales.

Stryker (SYK) Q2 Earnings and Revenues Surpass Estimates

Stryker's (SYK) second-quarter earnings reflect strong performance across Orthopaedics, MedSurg and Neurotechnology and Spine segments.

What's in Store for West Pharmaceutical's (WST) Q2 Earnings?

West Pharmaceutical's (WST) second-quarter results are likely to reflect strength in the Proprietary Products business.

Cardinal Health (CAH) Introduces 2 New Digital Solutions

Cardinal Health (CAH) launches NavixRx Compliance Packaging and E-Commerce Storefront to allow independent pharmacists to expand services and support medication adherence.

West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy?

West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Trina Mukherjee headshot

3 Stocks to Tap the Promising Dental Supplies Industry

Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical-Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

What Makes Align Technology (ALGN) a Solid Choice Right Now?

Strong performance and latest innovations in the Invisalign and iTero family are driving the top line for Align Technology (ALGN).

Trina Mukherjee headshot

Grab these 3 MedTech Stocks That Outperformed S&P 500 YTD

Snap up these three top stocks, WST, PAHC and RMD, which continue to show promise amid the pandemic and can turn out to be prudent investment choices.

West Pharmaceutical (WST) Hits 52-Week High: What's Driving It?

Investors are optimistic about West Pharmaceutical's (WST) solid proprietary products segment.